Krispy Kreme, Inc. — Form 8-K Summary
Business context and reporting period
This Form 8-K reports board changes and a Nasdaq continued-listing compliance matter. The report is dated June 29, 2022, with the filing signed July 6, 2022; the Nasdaq notification described was received July 6, 2022.
Financial and operating metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material changes
- Henry Yeagley resigned from the Board effective June 30, 2022. He also served on the Audit & Finance Committee.
- The filing states that Mr. Yeagley’s resignation was not caused, in whole or in part, by any disagreement with the Company or the Board.
- Gerhard Pleuhs was elected to the Board on June 30, 2022 and appointed to the Audit & Finance Committee and Remuneration & Nomination Committee.
- Mr. Pleuhs will participate in the Company’s standard director compensation program. The filing reports no related-party transaction or material arrangement requiring disclosure under the cited rules.
Outlook, risks, and contingencies
- Following the May 17, 2022 annual meeting, the Board no longer had a majority of independent directors, creating non-compliance with Nasdaq Listing Rule 5605(b)(1).
- Nasdaq notified the Company on July 6, 2022 and granted a cure period ending on the earlier of the next annual meeting or May 17, 2023. If the next annual meeting occurs before November 14, 2022, the cure period ends November 14, 2022.
- The Board is evaluating options to restore compliance and expects to regain compliance within the cure period.
- The Company stated that it remained compliant with all other Nasdaq continued-listing standards, including requirements that certain Board committees consist solely of independent directors.
Investor verification points
- Verify the timing and status of the Nasdaq cure period and whether the Board regained a majority of independent directors.
- Confirm Mr. Pleuhs’s independence classification and committee assignments.
- Review subsequent filings for any additional director changes, governance actions, or listing-status developments.
- Note that this filing contains no financial guidance or updated business outlook.